Beta Drugs Limited — Others, 12-03-2025: Shareholders meeting

Beta Drugs Ltd. has announced a board meeting regarding the results of a postal ballot where shareholders overwhelmingly approved several significant resolutions. These include the increase in the company’s authorized share capital, the issue of bonus shares, and the appointment of Mrs. Monica Jain and Mr. Lalit Kumar Watts as Independent Directors. Additionally, shareholders endorsed the migration of the company's share listing from the Emerge platform to the main boards of NSE and BSE. This broad support signifies strong confidence from shareholders and may enhance the company’s operational capabilities and market presence, fostering a positive outlook for future growth.